Cargando…

Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine–pyrimethamine in Benin

BACKGROUND: In sub-Saharan Africa, malaria is a major cause of morbidity and mortality, in particular in children and pregnant women. During pregnancy, Plasmodium falciparum infected red blood cells expressing VAR2CSA are selected from circulation by selective cytoadherence to chondroitin sulfate pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jafari-Guemouri, Sayeh, Dhiab, Jamila, Massougbodji, Achille, Deloron, Philippe, Tuikue, Ndam N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180446/ https://www.ncbi.nlm.nih.gov/pubmed/30305101 http://dx.doi.org/10.1186/s12936-018-2498-8

Ejemplares similares

A Genotyping Study in Benin Comparing the Carriage of Plasmodium falciparum Infections Before Pregnancy and in Early Pregnancy: Story of a Persistent Infection
por: Jafari-Guemouri, Sayeh, et al.
Publicado: (2020)

Sulfadoxine/Pyrimethamine Intermittent Preventive Treatment for Malaria during Pregnancy
por: Deloron, Philippe, et al.
Publicado: (2010)

High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin
por: Moussiliou, Azizath, et al.
Publicado: (2013)

Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in Northern Benin
por: Ogouyèmi-Hounto, Aurore, et al.
Publicado: (2013)

Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin
por: Bertin, Gwladys, et al.
Publicado: (2011)

Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy
por: Ogouyèmi-Hounto, Aurore, et al.
Publicado: (2013)

Intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine and parasite resistance: cross-sectional surveys from antenatal care visit and delivery in rural Ghana
por: Mama, Atikatou, et al.
Publicado: (2022)

A Randomized Open-Label Trial of Artesunate- Sulfadoxine-Pyrimethamine with or without Primaquine for Elimination of Sub-Microscopic P. falciparum Parasitaemia and Gametocyte Carriage in Eastern Sudan
por: El-Sayed, Badria, et al.
Publicado: (2007)

Expression of the Domain Cassette 8 Plasmodium falciparum Erythrocyte Membrane Protein 1 Is Associated with Cerebral Malaria in Benin
por: Bertin, Gwladys I., et al.
Publicado: (2013)

Molecular Aspects of Plasmodium falciparum Infection during Pregnancy
por: Ndam, Nicaise Tuikue, et al.
Publicado: (2007)

Effectiveness of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine in Pregnancy: Low Coverage and High Prevalence of Plasmodium falciparum dhfr-dhps Quintuple Mutants as Major Challenges in Douala, an Urban Setting in Cameroon
por: Eboumbou Moukoko, Carole Else, et al.
Publicado: (2023)

Suboptimal Intermittent Preventive Treatment in Pregnancy (IPTp) is Associated With an Increased Risk of Submicroscopic Plasmodium falciparum Infection in Pregnant Women: A Prospective Cohort Study in Benin
por: Hounkonnou, Cornélia P A, et al.
Publicado: (2020)

Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin
por: Ndam, Nicaise Tuikue, et al.
Publicado: (2015)

Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes
por: Atroosh, Wahib M., et al.
Publicado: (2016)

Dynamics in the Cytoadherence Phenotypes of Plasmodium falciparum Infected Erythrocytes Isolated during Pregnancy
por: Doritchamou, Justin, et al.
Publicado: (2014)

Submicroscopic placental infection by non-falciparum Plasmodium spp.
por: Doritchamou, Justin Y. A., et al.
Publicado: (2018)

Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania
por: Kavishe, Reginald A., et al.
Publicado: (2016)

Molecular Markers for Sulfadoxine/Pyrimethamine and Chloroquine Resistance in Plasmodium falciparum in Thailand
por: Kuesap, Jiraporn, et al.
Publicado: (2022)

Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria
por: Olowe, Rita A, et al.
Publicado: (2023)

Gametocyte carriage in Plasmodium falciparum-infected travellers
por: Roberts, Catherine H, et al.
Publicado: (2013)

Dynamics of Submicroscopic Plasmodium falciparum Infections Throughout Pregnancy: A Preconception Cohort Study in Benin
por: Hounkonnou, Cornélia P A, et al.
Publicado: (2020)

Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan
por: Elamin, Sakina B, et al.
Publicado: (2005)

Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum
por: Brock, Aleisha R., et al.
Publicado: (2017)

Intermittent presumptive treatment in pregnancy with sulfadoxine–pyrimethamine: a counter perspective
por: Nosten, Francois, et al.
Publicado: (2015)

Intermittent Preventive Treatment with Sulfadoxine–Pyrimethamine: More than Just an Antimalarial?
por: Gutman, Julie, et al.
Publicado: (2017)

Economic Evaluation of an Alternative Drug to Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy
por: Sicuri, Elisa, et al.
Publicado: (2015)

The remarkable tenacity of sulfadoxine-pyrimethamine
por: Divala, Titus H, et al.
Publicado: (2019)

Antibody Responses to Crude Gametocyte Extract Predict Plasmodium falciparum Gametocyte Carriage in Kenya
por: Omondi, Brian R., et al.
Publicado: (2021)

Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia
por: Lederman, Edith R, et al.
Publicado: (2006)

Low-grade sulfadoxine–pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola
por: Kaingona-Daniel, Elsa P. S., et al.
Publicado: (2016)

Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi
por: Ravenhall, Matt, et al.
Publicado: (2016)

Prevalence of molecular markers of sulfadoxine–pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan
por: Yaqoob, Adnan, et al.
Publicado: (2018)

Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in Africa: a systematic analysis of national trends
por: Amimo, Floriano, et al.
Publicado: (2020)

Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican Children
por: Quelhas, Diana, et al.
Publicado: (2012)

Changing the policy for intermittent preventive treatment with sulfadoxine–pyrimethamine during pregnancy in Malawi
por: Mwendera, Chikondi A., et al.
Publicado: (2017)

Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya
por: Bousema, J Teun, et al.
Publicado: (2004)

Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa
por: Nahum, Alain, et al.
Publicado: (2009)

High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania
por: Baraka, Vito, et al.
Publicado: (2015)

Origins and spread of novel genetic variants of sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates in Indonesia
por: Basuki, Sukmawati, et al.
Publicado: (2018)

Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990–2020
por: Flegg, Jennifer A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3jckgf1ulc8q2pb77mnebod5j6